Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Oleg V. Pyankov"'
Autor:
Tamara V. Teplyakova, Alexey S. Kabanov, Alena S. Ovchinnikova, Dmitry A. Odnoshevskyh, Irina F. Petrovskaya, Tatiana S. Nepomnyashchikh, Oleg V. Pyankov
Publikováno v:
Вопросы вирусологии, Vol 68, Iss 4, Pp 277-282 (2023)
Introduction. The mouse-specific orthopoxvirus, ectromelia virus, is one of the best models that can be used to study key issues of pathogenesis, prevention, and treatment of smallpox, and to develop measures to increase virulence, transmissibility,
Externí odkaz:
https://doaj.org/article/90be7552ab404c83abe87209f6eed99a
Autor:
Gleb A. Kudrov, Sergei S. Zainutdinov, Antonina A. Grazhdantseva, Andrey V. Shipovalov, Galina F. Sivolobova, Anastasiya V. Semenova, Iuliia A. Merkuleva, Dmitry N. Shcherbakov, Oleg S. Taranov, Anna V. Zaykovskaya, Irina S. Shulgina, Oleg V. Pyankov, Galina V. Kochneva
Publikováno v:
Вопросы вирусологии, Vol 68, Iss 3, Pp 215-227 (2023)
Introduction. Intranasal vaccination using live vector vaccines based on non-pathogenic or slightly pathogenic viruses is the one of the most convenient, safe and effective ways to prevent respiratory infections, including COVID-19. Sendai virus is t
Externí odkaz:
https://doaj.org/article/ebbcd55f46d94f42a34333396d16c6e1
Autor:
Andrey V. Shipovalov, Gleb A. Kudrov, Mikhail Yu. Kartashov, Irina A. Drachkova, Oleg V. Pyankov, Vladimir V. Omigov, Oleg S. Taranov, Tamara V. Teplyakova
Publikováno v:
Вопросы вирусологии, Vol 68, Iss 2, Pp 152-160 (2023)
Introduction. The COVID-19 pandemic combined with seasonal epidemics of respiratory viral diseases requires targeted antiviral prophylaxis with restorative and immunostimulant drugs. The compounds of natural origin are low-toxic, but active against s
Externí odkaz:
https://doaj.org/article/02189fe7c0ab4c7b9ff8bfe558364ada
Autor:
Olga I. Yarovaya, Aleksandr S. Filimonov, Dmitriy S. Baev, Sophia S. Borisevich, Anna V. Zaykovskaya, Varvara Yu. Chirkova, Mariya K. Marenina, Yulia V. Meshkova, Svetlana V. Belenkaya, Dmitriy N. Shcherbakov, Maxim A. Gureev, Olga A. Luzina, Oleg V. Pyankov, Nariman F. Salakhutdinov, Mikhail V. Khvostov
Publikováno v:
Viruses, Vol 16, Iss 2, p 215 (2024)
Although the COVID-19 pandemic caused by SARS-CoV-2 viruses is officially over, the search for new effective agents with activity against a wide range of coronaviruses is still an important task for medical chemists and virologists. We synthesized a
Externí odkaz:
https://doaj.org/article/f8027d82e2904b38a99ec1ab28d8aae6
Autor:
Anna A. Skoptsova, Athina Geronikaki, Nadezhda P. Novichikhina, Alexey V. Sulimov, Ivan S. Ilin, Vladimir B. Sulimov, Georgii A. Bykov, Nadezhda A. Podoplelova, Oleg V. Pyankov, Khidmet S. Shikhaliev
Publikováno v:
Molecules, Vol 29, Iss 2, p 373 (2024)
Cardiovascular diseases caused by blood coagulation system disorders are one of the leading causes of morbidity and mortality in the world. Research shows that blood clotting factors are involved in these thrombotic processes. Among them, factor Xa o
Externí odkaz:
https://doaj.org/article/2a0a169dc87845c2b9aa07136e480c8b
Autor:
Olga N. Shaprova, Daniil V. Shanshin, Evgeniia A. Kolosova, Sophia S. Borisevich, Artem A. Soroka, Iuliia A. Merkuleva, Artem O. Nikitin, Ekaterina A. Volosnikova, Nikita D. Ushkalenko, Anna V. Zaykovskaya, Oleg V. Pyankov, Svetlana A. Elchaninova, Dmitry N. Shcherbakov, Tatiana N. Ilyicheva
Publikováno v:
Antibodies, Vol 12, Iss 4, p 82 (2023)
In December 2019, a new coronavirus, SARS-CoV-2, was found to in Wuhan, China. Cases of infection were subsequently detected in other countries in a short period of time, resulting in the declaration of the COVID-19 pandemic by the World Health Organ
Externí odkaz:
https://doaj.org/article/60d5945dbe5242978ff1eea22b18388f
Autor:
Alexander B. Ryzhikov, Evgeny A. Ryzhikov, Marina P. Bogryantseva, Svetlana V. Usova, Elena A. Nechaeva, Elena D. Danilenko, Stepan A. Pyankov, Andrey S. Gudymo, Anastasiya A. Moiseeva, Galina S. Onkhonova, Oleg V. Pyankov, Ekaterina S. Sleptsova, Nikita V. Lomakin, Veronika S. Vasilyeva, Mikhail V. Tulikov, Vitaly G. Gusarov, Andrey A. Pulin, Maria A. Balalaeva, Svetlana B. Erofeeva, Stanislav A. Terpigorev, Olga A. Rychkova, Ivan M. Petrov, Viktoriia Y. Delian, Vladimir V. Rafalskiy, Sergey V. Tyranovets, Elena V. Gavrilova, Rinat A. Maksyutov
Publikováno v:
Vaccines, Vol 11, Iss 5, p 998 (2023)
The State Research Center of Virology and Biotechnology “VECTOR” of the Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has developed the peptide-based EpiVacCorona vaccine, which is the first synthetic pept
Externí odkaz:
https://doaj.org/article/200e423720e04b339bd6ba8dcab07260
Autor:
Ekaterina A. Volosnikova, Iuliia A. Merkuleva, Tatiana I. Esina, Dmitry N. Shcherbakov, Mariya B. Borgoyakova, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Natalia V. Volkova, Svetlana V. Belenkaya, Anna V. Zaykovskaya, Oleg V. Pyankov, Ekaterina V. Starostina, Alexey M. Zadorozhny, Boris N. Zaitsev, Larisa I. Karpenko, Alexander A. Ilyichev, Elena D. Danilenko
Publikováno v:
Vaccines, Vol 11, Iss 4, p 808 (2023)
Despite the rapid development and approval of several COVID vaccines based on the full-length spike protein, there is a need for safe, potent, and high-volume vaccines. Considering the predominance of the production of neutralizing antibodies targeti
Externí odkaz:
https://doaj.org/article/f1e47c9a247e478f964607cf1e5745a2
Autor:
Aleksandr S. Filimonov, Olga I. Yarovaya, Anna V. Zaykovskaya, Nadezda B. Rudometova, Dmitriy N. Shcherbakov, Varvara Yu. Chirkova, Dmitry S. Baev, Sophia S. Borisevich, Olga A. Luzina, Oleg V. Pyankov, Rinat A. Maksyutov, Nariman F. Salakhutdinov
Publikováno v:
Viruses, Vol 14, Iss 10, p 2154 (2022)
In order to test the antiviral activity, a series of usnic acid derivatives were synthesized, including new, previously undescribed compounds. The activity of the derivatives against three strains of SARS-CoV-2 virus was studied. To understand the me
Externí odkaz:
https://doaj.org/article/76f774f4204142e9bc4b2b0c5d7f7224
Autor:
Olga I. Yarovaya, Dmitriy N. Shcherbakov, Sophia S. Borisevich, Anastasiya S. Sokolova, Maxim A. Gureev, Edward M. Khamitov, Nadezda B. Rudometova, Anastasiya V. Zybkina, Ekaterina D. Mordvinova, Anna V. Zaykovskaya, Artem D. Rogachev, Oleg V. Pyankov, Rinat A. Maksyutov, Nariman F. Salakhutdinov
Publikováno v:
Viruses, Vol 14, Iss 6, p 1295 (2022)
In the present work we studied the antiviral activity of the home library of monoterpenoid derivatives using the pseudoviral systems of our development, which have glycoproteins of the SARS-CoV-2 virus strains Wuhan and Delta on their surface. We fou
Externí odkaz:
https://doaj.org/article/0801fba33b9444c79b2014fcc3bb8a46